CHEPLAPHARM Arzneimittel GmbH
PolandAll drugs from this manufacturer
-
The drug is used in the treatment of bladder emptying disorders (resulting from bladder muscle flaccidity in neurological diseases), constipation caused by intestinal muscle flaccidity, and as support in the treatment of pathological muscle weakness (myasthenia).
Dosage form: tablets
Active substance Dosage distigmine bromide 5 mg ATC: N07AA03
-
It is used for the topical treatment of moderate to severe acne, especially when previous non-antibiotic treatment has been ineffective or not tolerated by the skin.
Dosage form: powder and solvent for preparation of solution for skin application
Active substance Dosage erythromycin 40 mg/ml zinc 12 mg/ml ATC: D10AF52
-
It is intended for the topical treatment of moderate to severe acne, especially when previous non-antibiotic treatment has been ineffective or not tolerated.
Dosage form: powder and solvent for preparation of solution for skin application
Active substance Dosage erythromycin 40 mg/ml zinc 12 mg/ml ATC: D10AF52
-
It is an anti-acne medication used topically for moderate to severe acne, especially when previous treatment without antibiotics has not been effective.
Dosage form: powder and solvent for preparation of solution for skin application
Active substance Dosage erythromycin 40 mg/ml zinc 12 mg/ml ATC: D10AF52
-
It is intended for the topical treatment of moderate to severe acne, especially when other non-antibiotic methods have not been effective or were not tolerated.
Dosage form: powder and solvent for preparation of solution for skin application
Active substance Dosage erythromycin 40 mg/ml zinc 12 mg/ml ATC: D10AF52
-
It is intended for the topical treatment of moderate to severe acne, especially when previous non-antibiotic treatment has been ineffective or poorly tolerated.
Dosage form: powder and solvent for preparation of solution for skin application
Active substance Dosage erythromycin 40 mg/ml zinc 12 mg/ml ATC: D10AF52